Tris DBA palladium is an orally available inhibitor of GNAQ mutant uveal melanoma <i>in vivo</i>

Elgilda Musi(Columbia University Irving Medical Center), Jack L. Arbiser(Emory University)
Oncotarget
July 8, 2019
Cited by 7


Related Papers